Combination therapy as the initial drug treatment for hypertension: When is it appropriate?

American Journal of Hypertension

Volumn 14, Issue 3, 2001, Pages 293-295

  Materson, Barry J ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; HYPERTENSION; KIDNEY FAILURE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; TREATMENT OUTCOME;

EID: 0035092288     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(00)01259-0     Document Type: Editorial

References (9)

1. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo
2. Department of Veterans Affairs Single-Drug therapy of hypertension study: Revised figures and new data
3. Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg
4. Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg
5. Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and prior cardiovascular disease: Further analysis of side effects
6. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
7. Lessons from combination therapy in Veterans Affairs studies
8. Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug
9. Results of combination anti-hypertensive therapy after failure of each of the components